ED-FBGP200

The DIASTAT™ anti-ß₂-glycoprotein 1 IgG (ß₂GP1) test is a quantitative/qualitative enzyme-linked immunosorbent assay (ELISA) for the detection of the IgG class of autoantibodies specific for ß₂GP1 antigen in human serum or citrate/EDTA anticoagulated plasma. It is intended to aid in the assessment of thrombotic risk in patients with autoimmune disease associated with thrombotic disorders such as primary anti-phospholipid syndrome or secondary to systemic lupus erythematosus. It is not definitive in isolation. Autoantibody levels represent one parameter in a multicriterion diagnostic process.

References:

McNally T, Mackie IJ, et al. Blood Coagulation and Fibrinolysis, 6, 411-416, 1995.

McNally T, Mackie IJ, et al. Thrombosis & Haemostasis, 76, 220-225, 1996.

Matsuura E and Koike T. Autoantibodies, Eds. Peter JB and Shoenfeld Y, Elsevier, Amsterdam, 109-114, 1996.

Khamashta MA and Hughes GRV. Autoantibodies, Eds. Peter JB and Shoenfeld Y, Elsevier, Amsterdam, 624-629, 1996.

Viard JP, Amoura Z, and Bach JF. Am J Med, 93, 181-186, 1992.

McNally T, Mackie IJ, et al. Br J Rheum, 34, 1031-1036, 1995.

Martinuzzo ME, Forastiero RR and Carreras LO. Br J Haem, 89, 397-402, 1995.

McNally T, Purdy G, et al. Br J Haem, 91, 471-473, 1995.